NDAQ Nasdaq Inc.

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Bra

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market

NEW YORK,, March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.’s securities were suspended on August 10, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals, Inc.’s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Collective Audience, Inc. Collective Audience, Inc.’s warrants were suspended on November 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of SeqLL Inc. SeqLL Inc.’s securities were suspended on November 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Nemaura Medical Inc. Nemaura Medical Inc.’s securities were suspended on January 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of LumiraDx Limited. LumiraDx Limited’s securities were suspended on January 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Series 1 Preferred Stock of Cemtrex Inc. Cemtrex Inc.’s shares of Series 1 Preferred Stock were suspended on January 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the perpetual preferred stock, common stock, and warrants of COMSovereign Holding Corp. COMSovereign Holding Corp.’s shares of perpetual preferred stock were suspended on January 23, 2024; the company’s shares of common stock and warrants were suspended on January 31, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Global System Dynamics. Global System Dynamics’s securities were suspended on January 24, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Arrival. Arrival’s securities were suspended on January 30, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrant of Nubia Brand International Corp. Nubia Brand International Corp.’s securities were suspended on February 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of The Alkaline Water Company Inc. The Alkaline Water Company Inc.’s securities were suspended on February 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DMK Pharmaceuticals Corporation. DMK Pharmaceuticals Corporation’s securities were suspended on February 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of MedAvail Holdings, Inc. MedAvail Holdings, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ADDvantage Technologies Group, Inc. ADDvantage Technologies Group, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .



EN
20/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE

Nasdaq CFO Sarah Youngwood to Present at Barclays Annual Global Financ...

Nasdaq CFO Sarah Youngwood to Present at Barclays Annual Global Financial Services Conference NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.com. Who:      Sarah Youngwood, Executive Vice President & CFO, Nasdaq   What: Barclays 23rd Annual Global Financial Services Conference   When: Monday, September 8th, 2025, 9:00 AM ET    About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment m...

 PRESS RELEASE

Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Partici...

Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure Strategic financing supports Puro.earth initiatives to accelerate carbon removal at scale HELSINKI, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Puro.earth, a leading carbon-crediting platform for engineered carbon dioxide removal (CDR), today announced it has raised €11 million in a Series B funding round led by with participation from Fortum Innovation & Venturing. Puro.earth will deploy this funding to strengthen the infrastructure that supp...

 PRESS RELEASE

Nasdaq Proposes Changes to its Listing Standards

Nasdaq Proposes Changes to its Listing Standards NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq proposed a new set of enhancements to its initial and continued listing standards, reinforcing its long-standing commitment to capital formation while ensuring investor protection and upholding market integrity. These proposed updates introduce enhanced requirements for minimum company public float and capital raised during initial public offerings, alongside stricter suspension and delisting procedures for companies failing to meet Nasdaq’s continued listings standards. The revi...

 PRESS RELEASE

Nasdaq Reports August 2025 Volumes

Nasdaq Reports August 2025 Volumes NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for August 2025 on its Investor Relations website. A data sheet showing this information can be found at: . About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integr...

 PRESS RELEASE

Nasdaq Verafin and BioCatch Form Strategic Partnership to Accelerate t...

Nasdaq Verafin and BioCatch Form Strategic Partnership to Accelerate the Global Fight Against Financial Crime Partnership combines industry-leading consortium data and behavioral intelligence to bolster financial institutions’ defense against fraud NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq Verafin and BioCatch today announced the formation of a strategic partnership to leverage their complementary technology solutions in the fight against payments fraud. The partnership aligns Nasdaq Verafin’s fraud detection platform and consortium data network with BioCatch’s behavioral and ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch